Allowing patients to keep using their personal diabetes technology during hospitalization improves glycemic control and reduces length of stay.

Welcome to this week’s rundown of what’s happening in the medical device industry. It’s been a pretty busy week with some big ...

Sports nutrition can enhance training adaptations and race performances, but only if you choose the right ones. Here are the best supplements for improving athletic ...

Tandem Diabetes Care issued an urgent medical device correction to upgrade the software of its Tandem Mobi insulin pumps that ...

The FDA cleared an automated insulin delivery system for use by pregnant women with type 1 diabetes, according to an industry ...

The FDA has classified a corrective action for Tandem Diabetes Care’s Mobi insulin pumps as a Class I recall, its highest ...

Insulin pump use during hospitalization may improve glycemic outcomes and reduce length of stay for people with diabetes, ...

Tandem Diabetes Care has announced that the U.S. Food and Drug Administration (FDA) has cleared Control-IQ+ automated insulin delivery (AID) technology for use in pregnancy complicated by ...

The FDA has cleared Tandem’s Control-IQ technology as the first ever AID specifically for use in pregnancies complicated by ...

A malfunction may cause insulin delivery to stop. Tandem instructed users to update their pump software as soon as possible.